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Sirs,
With interest we have read the article entitled ‘‘Antioxi-
dant effect of cysteamine in brain cortex of young rats’’ by
Kessler et al. [1]. In their study, they showed that cysteamine
reduces the oxidative stress caused by administration of
cystine dimethyl ester (CDME) in Wistar rats.
In contrast to the antioxidant effects of cysteamine via
increased production of glutathion, Jeitner and Lawrence
showed that a higher dose of cysteamine induced cyto-
toxicity by enhanced H2O2 production [2]. In addition, the
proposed antioxidant effects of cysteamine observed in rats
with CDME administration can be different in patients with
cystinosis, as Kessler et al. mentioned in their recent paper.
Because research to the pathogenesis of cystinosis was
hampered by the lack of a proper in vitro model, many
studies have used CDME for its ability to artificially load
lysosomes with cystine, mimicking lysosomal cystine
accumulation in cystinosis. This technique has been
developed in the 70s by Goldman and Reeves [3, 4]. Using
CDME loading, alterations in ATP metabolism and
increased apoptosis have been demonstrated [5, 6]. More
recent studies in human cystinotic tissues indicated the
involvement of oxidative stress, possibly via alterations in
glutathion metabolism [7–9].
Our group has recently shown that loading of cultured
fibroblasts and human proximal tubular cells with CDME
has a direct impact on the viability of the cells by irre-
versible inhibition of the mitochondrial ATP production
and burst of superoxide in the cells [10]. These major
effects were not observed in cystinotic cells with compa-
rable cystine levels due to mutations in the CTNS gene.
This indicates a direct toxic effect of CDME, independent
of cystine accumulation.
Based on these data we recommend that the use of CDME
should be limited for studying the pathogenesis of cystinosis
and conclusions drawn using this model need re-evaluation.
Instead, more appropriate cell and animal models with
defective CTNS, which already have been developed by
several groups, can be used for this purpose [11–13].
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